Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2025)
Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
OM	OUTSET MEDICAL INC	$228.44M	-145.40%	-38.40%	-34.42%	-25.50%	0.77	8.37	35.90%	-98.70%	-79.73%
SRPT	SAREPTA THERAPEUTICS INC	$1.98B	-4.40%	-1.60%	-0.87%	-0.60%	1.71	2.89	79.30%	-2.30%	-0.97%
RSLS	RESHAPE LIFESCIENCES INC	$2.89M	-251.90%	-59.50%	-143.64%	-444.60%	4.27	1.53	63.70%	-48.30%	-47.25%
AMWL	AMERICAN WELL CORP	$117.43M	-40.90%	-28.80%	-41.00%	-1,817.90%	0.33	3.30	49.00%	-46.20%	-45.70%
ICLR	ICON PLC	$13.64B	8.30%	4.70%	7.27%	22.40%	0.74	1.29	28.60%	9.80%	12.61%
GERN	GERON CORP	$925.12M	-32.00%	-16.30%	-12.13%	-10.20%	1.14	7.87	97.80%	-53.50%	-36.21%
NRXP	NRX PHARMACEUTICALS INC	$46.16M	N/A	-460.00%	95.82%	166.60%	-1.30	0.22	N/A	N/A	N/A
EVO	EVOTEC SE	$1.36B	-16.90%	-8.10%	-8.51%	-8.40%	1.14	1.58	12.90%	-20.00%	-15.61%
ACHC	ACADIA HEALTHCARE COMPANY INC	$1.91B	4.60%	2.30%	5.39%	5.90%	1.00	1.32	34.80%	4.30%	9.65%
EUDA	EUDA HEALTH HOLDINGS LTD	$96.60M	N/A	-1,021.00%	626.82%	513.40%	-1.67	0.18	19.00%	-382.90%	-381.87%
AAPG	ASCENTAGE PHARMA GROUP INTERNATIONAL	$3.70B	-1,337.40%	-15.90%	-22.94%	-16.90%	8.87	1.26	97.00%	-41.30%	-33.71%
QIPT	QUIPT HOME MEDICAL CORP	$86.45M	-9.80%	-4.20%	-2.31%	-2.70%	1.30	1.15	18.10%	-4.50%	-1.78%
SLP	SIMULATIONS PLUS INC	$285.80M	-37.10%	-34.70%	-55.87%	-274.70%	0.09	5.11	53.70%	-78.60%	-86.34%
ZLAB	ZAI LAB LTD	$3.79B	-33.30%	-23.30%	-29.14%	-151.50%	0.45	3.26	63.50%	-60.30%	-59.46%
ACOG	ALPHA COGNITION INC	$128.16M	-59.70%	-43.70%	-25.18%	5,752.40%	0.19	17.14	71.40%	-397.50%	-393.86%
PRE	PRENETICS GLOBAL LTD	$99.99M	-27.60%	-21.70%	-33.54%	-58.30%	0.27	2.07	45.70%	-115.90%	-134.35%
XGN	EXAGEN INC	$205.62M	-136.30%	-36.30%	-29.17%	-37.60%	1.79	4.95	59.40%	-28.80%	-24.02%
MESO	MESOBLAST LTD	$1.83B	-21.30%	-15.60%	-13.73%	-79.50%	0.42	0.96	100.00%	-1,822.80%	-1,405.84%
UNH	UNITEDHEALTH GROUP INC	$245.88B	22.60%	7.00%	15.12%	25.80%	2.15	0.85	20.80%	5.00%	7.07%
UTHR	UNITED THERAPEUTICS CORP	$14.11B	18.70%	16.50%	22.33%	31.40%	0.10	7.26	89.00%	40.40%	53.56%
CADL	CANDEL THERAPEUTICS INC	$302.62M	-136.70%	-63.10%	-49.88%	1,373.50%	0.28	4.64	N/A	N/A	N/A
IRD	OPUS GENETICS INC	$70.69M	-366.70%	-142.10%	-315.46%	614.70%	1.21	1.90	100.00%	-377.90%	-377.89%
CUPR	CUPRINA HOLDINGS (CAYMAN) LTD	$204.45M	N/A	-93.70%	35.46%	44.10%	-1.39	0.27	-6.30%	-3,229.50%	-3,152.53%
TAOX	TAO SYNERGIES INC	$12.78M	-121.70%	-61.50%	-80.54%	1,303.90%	1.72	72.71	N/A	N/A	N/A
SSII	SS INNOVATIONS INTERNATIONAL INC	$1.31B	-60.50%	-31.10%	-30.49%	-43.40%	0.67	2.59	49.20%	-66.20%	-61.11%
KROS	KEROS THERAPEUTICS INC	$585.67M	3.00%	2.70%	3.72%	61.90%	0.07	21.11	100.00%	8.10%	11.55%
ALC	ALCON INC	$43.02B	5.20%	3.70%	5.32%	11.20%	0.41	2.70	55.50%	11.30%	15.43%
LFCR	LIFECORE BIOMEDICAL INC	$274.73M	-788.60%	-19.90%	-10.94%	-7.10%	85.36	2.71	33.40%	-37.90%	-17.34%
BFLY	BUTTERFLY NETWORK INC	$354.95M	-30.50%	-21.80%	-22.89%	-46.00%	0.35	5.68	62.00%	-71.80%	-70.25%
SGRY	SURGERY PARTNERS INC	$2.88B	-10.10%	-2.30%	2.40%	3.10%	2.75	1.93	23.70%	-5.60%	5.46%
FBIO	FORTRESS BIOTECH INC	$58.32M	-87.40%	-15.80%	-0.19%	-0.40%	2.79	1.92	70.90%	-40.60%	-0.34%
ANAB	ANAPTYSBIO INC	$559.10M	-367.00%	-30.60%	-44.21%	-20.90%	-8.49	8.22	100.00%	-107.70%	-107.59%
TLX	TELIX PHARMACEUTICALS LTD	$3.68B	13.90%	5.20%	7.84%	27.90%	1.67	2.78	65.10%	6.40%	11.87%
ALMS	ALUMIS INC	$456.84M	-72.10%	-56.00%	-44.94%	-116.10%	0.26	6.05	100.00%	-1,134.50%	-1,177.16%
SION	SIONNA THERAPEUTICS INC	$922.96M	N/A	N/A	N/A	N/A	0.05	35.33	N/A	N/A	N/A
CTEV	CLARITEV CORP	$1.11B	-517.70%	-22.10%	-19.64%	-19.90%	341.97	1.02	74.10%	-127.00%	-103.84%
MOH	MOLINA HEALTHCARE INC	$8.65B	24.90%	7.10%	19.84%	37.30%	2.52	1.67	10.90%	2.60%	3.81%
IART	INTEGRA LIFESCIENCES HOLDINGS CORP	$1.06B	-35.60%	-12.70%	-17.55%	-18.30%	2.53	1.23	52.60%	-30.90%	-29.63%
PBH	PRESTIGE CONSUMER HEALTHCARE INC	$3.19B	12.20%	6.40%	10.07%	23.80%	0.85	4.21	55.80%	18.90%	29.16%
STOK	STOKE THERAPEUTICS INC	$940.87M	18.30%	15.50%	11.73%	30.70%	0.15	6.98	100.00%	26.30%	20.30%
CDTX	CIDARA THERAPEUTICS INC	$824.23M	-132.70%	-98.60%	-128.03%	831.10%	0.35	3.87	100.00%	-60,589.70%	-60,589.74%
NAMS	NEWAMSTERDAM PHARMA CO NV	$2.83B	-24.60%	-22.60%	-21.28%	-324.10%	0.05	21.09	100.00%	-258.90%	-258.91%
TCRX	TSCAN THERAPEUTICS INC	$102.71M	-63.80%	-40.50%	-50.02%	-56.20%	0.69	7.06	100.00%	-1,964.90%	-1,920.20%
ALT	ALTIMMUNE INC	$324.79M	-62.60%	-55.30%	-48.67%	-113.70%	0.18	20.44	100.00%	-584,973.30%	-587,700.00%
HRTX	HERON THERAPEUTICS INC	$205.96M	N/A	-3.40%	-3.60%	-1.80%	-9.29	2.40	74.00%	-5.20%	-3.57%
RNAC	CARTESIAN THERAPEUTICS INC	$296.66M	N/A	-10.30%	-9.65%	-20.90%	-19.78	12.34	100.00%	-124.40%	-111.27%
ARAY	ACCURAY INC	$150.40M	1.40%	0.10%	8.29%	6.50%	8.77	1.64	31.50%	0.10%	5.00%
ATAI	ATAI LIFE SCIENCES NV	$803.35M	-102.40%	-77.60%	-87.19%	-89.70%	0.29	4.07	100.00%	-7,997.20%	-7,828.56%
ALGS	ALIGOS THERAPEUTICS INC	$46.66M	-123.90%	-66.80%	-53.70%	-107.30%	0.32	6.31	100.00%	-2,337.20%	-1,936.36%
IPSC	CENTURY THERAPEUTICS INC	$47.51M	-11.50%	-6.90%	-7.97%	-8.70%	0.36	10.72	100.00%	-20.40%	-18.85%
SNDA	SONIDA SENIOR LIVING INC	$481.31M	-58.90%	-4.70%	0.66%	0.40%	12.98	0.85	22.10%	-11.10%	1.44%
RYTM	RHYTHM PHARMACEUTICALS INC	$6.41B	-1,884.80%	-49.70%	-66.25%	-95.90%	-20.08	2.79	89.20%	-120.50%	-103.12%
ARWR	ARROWHEAD PHARMACEUTICALS INC	$2.59B	-46.00%	-12.50%	-5.81%	-4.80%	1.30	5.15	100.00%	-26.40%	-14.41%
HTFL	HEARTFLOW INC	N/A	N/A	N/A	N/A	N/A	-0.34	3.33	N/A	N/A	N/A
IGMS	IGM BIOSCIENCES INC	$76.57M	-93.40%	-24.20%	-52.89%	-27.90%	0.06	17.66	100.00%	-36.80%	-36.80%
ARVN	ARVINAS INC	$519.80M	-12.00%	-7.00%	-9.65%	-9.90%	0.49	5.64	100.00%	-19.50%	-19.45%
NEO	NEOGENOMICS INC	$800.91M	-11.70%	-6.60%	-7.70%	-13.80%	0.63	3.92	43.90%	-15.10%	-14.46%
NTRA	NATERA INC	$21.63B	-18.30%	-11.70%	-13.23%	-25.70%	0.40	3.87	61.80%	-10.40%	-9.87%
CHE	CHEMED CORP	$6.47B	24.50%	16.90%	26.80%	65.30%	0.43	1.86	33.60%	11.60%	15.51%
CNC	CENTENE CORP	$13.23B	7.50%	2.40%	6.96%	11.70%	2.15	1.10	8.90%	1.20%	1.94%
MBIO	MUSTANG BIO INC	$7.79M	N/A	-107.30%	-284.92%	103.30%	3.13	1.34	N/A	N/A	N/A
ANIK	ANIKA THERAPEUTICS INC	$124.57M	-38.50%	-29.80%	-33.47%	-40.90%	0.27	6.18	57.80%	-66.00%	-62.53%
PROK	PROKIDNEY CORP	$712.16M	N/A	-17.10%	-20.84%	-23.90%	-0.03	11.48	100.00%	-13,752.20%	-13,599.62%
PACS	PACS GROUP INC	$1.76B	N/A	N/A	N/A	N/A	5.80	1.71	N/A	N/A	N/A
TSHA	TAYSHA GENE THERAPIES INC	$802.02M	-79.90%	-45.70%	-30.08%	-175.00%	0.34	12.48	100.00%	-1,145.00%	-1,143.96%
PVLA	PALVELLA THERAPEUTICS INC	$509.85M	-58.40%	-40.60%	-31.83%	371.60%	0.54	7.67	100.00%	50,203.80%	38,513.21%
ARCT	ARCTURUS THERAPEUTICS HOLDINGS INC	$522.18M	-24.90%	-17.80%	-28.76%	-206.10%	0.34	5.90	100.00%	-49.30%	-61.89%
GLUE	MONTE ROSA THERAPEUTICS INC	$267.57M	2.70%	1.70%	2.83%	4.70%	0.43	5.61	100.00%	3.90%	5.93%
PHIO	PHIO PHARMACEUTICALS CORP	$10.51M	-105.70%	-89.20%	-55.59%	862.90%	0.10	10.58	N/A	N/A	N/A
LEGN	LEGEND BIOTECH CORP	$6.96B	-30.90%	-19.40%	-19.89%	-40.60%	0.63	4.71	62.50%	-40.80%	-35.56%
CVAC	CUREVAC NV	$1.24B	29.60%	24.40%	30.83%	84.20%	0.15	7.65	87.60%	34.50%	40.09%
NRC	NATIONAL RESEARCH CORP	$341.78M	71.30%	18.70%	36.04%	47.00%	3.56	0.54	60.30%	17.10%	24.85%
CTMX	CYTOMX THERAPEUTICS INC	$141.89M	-553.10%	32.20%	86.63%	-811.10%	2.93	1.73	100.00%	28.20%	28.35%
RGC	REGENCELL BIOSCIENCE HOLDINGS LTD	$6.28B	-42.50%	-40.90%	-52.18%	-52.80%	0.03	41.92	N/A	N/A	N/A
ACRS	ACLARIS THERAPEUTICS INC	$183.00M	-92.40%	-68.40%	-73.74%	-94.90%	0.38	5.06	14.90%	-732.40%	-732.42%
IVVD	INVIVYD INC	$95.85M	-165.20%	-99.70%	-263.57%	2,600.20%	0.92	1.53	93.30%	-389.00%	-389.00%
INBX	INHIBRX BIOSCIENCES INC	$346.78M	-137.80%	-76.30%	-91.16%	-390.10%	2.09	4.98	100.00%	-11,692.40%	-11,275.86%
BBIO	BRIDGEBIO PHARMA INC	$9.78B	N/A	-87.60%	-70.83%	-29.80%	-1.60	5.19	96.20%	-329.30%	-271.62%
PBM	PSYENCE BIOMEDICAL LTD	$1.90M	-47.60%	24.00%	15.19%	-57.90%	0.09	11.04	N/A	N/A	N/A
MNKD	MANNKIND CORP	$1.14B	-32.60%	7.80%	22.86%	11.40%	-8.48	2.50	74.90%	10.90%	22.71%
NRIX	NURIX THERAPEUTICS INC	$807.31M	-45.30%	-34.70%	-40.02%	-45.80%	0.32	6.82	100.00%	-234.60%	-233.61%
ADMA	ADMA BIOLOGICS INC	$4.05B	61.80%	42.90%	32.10%	37.00%	0.40	5.33	53.00%	44.10%	32.73%
LIXT	LIXTE BIOTECHNOLOGY HOLDINGS INC	$10.47M	-237.50%	-189.30%	-285.68%	1,253.10%	0.31	4.26	N/A	N/A	N/A
PTHL	PHETON HOLDINGS LTD	$9.50M	N/A	N/A	-10.33%	N/A	0.09	12.40	85.00%	-147.40%	-142.52%
GALT	GALECTIN THERAPEUTICS INC	$237.98M	N/A	-216.70%	38.45%	-66.50%	-1.07	0.08	N/A	N/A	N/A
MAZE	MAZE THERAPEUTICS INC	$585.41M	N/A	N/A	N/A	N/A	0.16	13.63	N/A	N/A	N/A
SLS	SELLAS LIFE SCIENCES GROUP INC	$163.21M	-132.50%	-92.80%	-99.82%	790.00%	0.24	4.91	N/A	N/A	N/A
ICU	SEASTAR MEDICAL HOLDING CORP	$24.56M	N/A	-232.70%	-437.86%	393.00%	1.51	1.52	96.50%	-1,915.30%	-1,909.79%
INSP	INSPIRE MEDICAL SYSTEMS INC	$2.50B	7.90%	6.80%	8.30%	9.50%	0.18	6.14	84.50%	6.20%	6.83%
TNYA	TENAYA THERAPEUTICS INC	$154.34M	-93.80%	-75.70%	-90.98%	-101.70%	0.22	6.00	N/A	N/A	N/A
ACIU	AC IMMUNE SA	$213.87M	-49.00%	-23.10%	-55.17%	-112.50%	1.55	1.33	100.00%	-174.70%	-174.09%
BLFS	BIOLIFE SOLUTIONS INC	$1.20B	-3.10%	-2.70%	-2.91%	-10.10%	0.12	4.73	69.60%	-13.10%	-13.46%
INSM	INSMED INC	$23.27B	-447.00%	-52.70%	-59.08%	-45.80%	17.18	5.86	76.50%	-265.90%	-242.45%
ERAS	ERASCA INC	$445.36M	-31.20%	-26.30%	-30.74%	-29.10%	0.20	11.04	N/A	N/A	N/A
EVAX	EVAXION A	$4.01M	N/A	-83.30%	-101.42%	-70.50%	-8.56	2.01	100.00%	-316.00%	-246.17%
ABCL	ABCELLERA BIOLOGICS INC	$1.34B	-15.70%	-12.20%	-16.60%	-19.30%	0.31	10.15	100.00%	-726.20%	-911.24%
CCRN	CROSS COUNTRY HEALTHCARE INC	$426.23M	-2.00%	-1.40%	-1.07%	-2.30%	0.34	3.21	20.20%	-0.70%	-0.41%
GHRS	GH RESEARCH PLC	$792.41M	-16.70%	-16.10%	-13.28%	-54.40%	0.03	29.49	N/A	N/A	N/A
ANIX	ANIXA BIOSCIENCES INC	$95.67M	-64.10%	-60.40%	-80.41%	-72.00%	0.13	8.89	N/A	N/A	N/A
MNPR	MONOPAR THERAPEUTICS	$221.25M	-41.80%	-39.50%	-33.11%	-198.40%	0.03	33.94	N/A	N/A	N/A

Healthcare Industries

Industry	Stocks	1d %	1w %	1m %	1y %	P/E ratio	P/B Ratio	ROE	ROA	ROCE	Upside/Downside	Consensus
Biotechnology	637	+0.16%	+4.39%	+5.40%	-64.07%	-116.18x	4.42x	-121.17%	-6.90%	-1.45%	+91.91%	Strong Buy
Diagnostics & Research	57	-0.65%	+5.82%	+10.75%	-11.64%	23.48x	3.84x	-3.66%	+7.34%	+14.22%	+6.42%	Buy
Drug Manufacturers - General	18	+1.22%	+4.73%	-2.89%	-13.96%	34.55x	5.87x	+58.71%	+10.34%	+17.79%	+52.31%	Buy
Drug Manufacturers - Specialty & Generic	77	+0.28%	+7.01%	+1.44%	-66.95%	-10.62x	2.24x	+12.23%	+4.91%	+10.43%	+33.61%	Buy
Healthcare Plans	11	+0.15%	+7.00%	-6.09%	-38.26%	13.12x	1.76x	+15.36%	+4.82%	+11.26%	+25.76%	Buy
Health Information Services	55	-0.70%	+5.29%	+3.12%	-55.42%	80.97x	4.02x	+7.39%	+4.83%	+9.55%	+21.87%	Strong Buy
Medical Care Facilities	48	-0.63%	+4.80%	+0.49%	-32.55%	15.89x	4.70x	-194.08%	+6.86%	+15.22%	+19.15%	Buy
Medical Devices	141	-0.80%	+4.06%	-1.62%	-20.79%	31.59x	3.98x	+13.01%	+8.47%	+10.00%	+30.11%	Strong Buy
Medical Distribution	10	+1.29%	+2.12%	-4.82%	+20.45%	26.65x	289.07x	-6.50%	+3.03%	+18.71%	+15.90%	Buy
Medical Instruments & Supplies	55	-1.07%	+2.00%	+0.19%	-60.20%	32.98x	3.50x	+10.58%	+8.31%	+11.13%	+23.54%	Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in Aug 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best healthcare stocks to buy right now are:

1. Phibro Animal Health (NASDAQ:PAHC)

Phibro Animal Health (NASDAQ:PAHC) is the #1 top healthcare stock out of 1109 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Phibro Animal Health (NASDAQ:PAHC) is: Value: A, Growth: A, Momentum: B, Sentiment: A, Safety: B, Financials: C, and AI: B.

Phibro Animal Health (NASDAQ:PAHC) has a Due Diligence Score of 45, which is 20 points higher than the healthcare sector average of 25. It passed 16 out of 38 due diligence checks and has strong fundamentals. Phibro Animal Health has seen its stock return 75.79% over the past year, overperforming other healthcare stocks by 124 percentage points.

Phibro Animal Health has an average 1 year price target of $30.50, a downside of -0.23% from Phibro Animal Health's current stock price of $30.57.

Phibro Animal Health stock has a consensus Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Phibro Animal Health, 50% have issued a Strong Buy rating, 0% have issued a Buy, 50% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Embecta (NASDAQ:EMBC)

Embecta (NASDAQ:EMBC) is the #2 top healthcare stock out of 1109 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Embecta (NASDAQ:EMBC) is: Value: A, Growth: A, Momentum: D, Sentiment: B, Safety: D, Financials: A, and AI: A.

Embecta (NASDAQ:EMBC) has a Due Diligence Score of 31, which is 6 points higher than the healthcare sector average of 25. It passed 11 out of 38 due diligence checks and has average fundamentals. Embecta has seen its stock lose -5.97% over the past year, overperforming other healthcare stocks by 42 percentage points.

Embecta has an average 1 year price target of $12.00, a downside of -13.48% from Embecta's current stock price of $13.87.

Embecta stock has a consensus Hold recommendation according to Wall Street analysts. Of the 1 analyst covering Embecta, 0% have issued a Strong Buy rating, 0% have issued a Buy, 100% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Theravance Biopharma (NASDAQ:TBPH)

Theravance Biopharma (NASDAQ:TBPH) is the #3 top healthcare stock out of 1109 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Theravance Biopharma (NASDAQ:TBPH) is: Value: B, Growth: A, Momentum: C, Sentiment: B, Safety: D, Financials: A, and AI: C.

Theravance Biopharma (NASDAQ:TBPH) has a Due Diligence Score of 39, which is 14 points higher than the healthcare sector average of 25. It passed 12 out of 33 due diligence checks and has average fundamentals. Theravance Biopharma has seen its stock return 58.19% over the past year, overperforming other healthcare stocks by 106 percentage points.

Theravance Biopharma has an average 1 year price target of $21.33, an upside of 64.86% from Theravance Biopharma's current stock price of $12.94.

Theravance Biopharma stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Theravance Biopharma, 66.67% have issued a Strong Buy rating, 33.33% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the healthcare stocks with highest dividends?

Out of 71 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Simulations Plus (NASDAQ:SLP)

Simulations Plus (NASDAQ:SLP) has an annual dividend yield of N/A, which is N/A percentage points lower than the healthcare sector average of 2%. Simulations Plus's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Simulations Plus's dividend has shown consistent growth over the last 10 years.

Simulations Plus's dividend payout ratio of -1.9% indicates that its dividend yield might not be sustainable for the long-term.

2. Dr Reddys Laboratories (NYSE:RDY)

Dr Reddys Laboratories (NYSE:RDY) has an annual dividend yield of N/A, which is N/A percentage points lower than the healthcare sector average of 2%. Dr Reddys Laboratories's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Dr Reddys Laboratories's dividend has shown consistent growth over the last 10 years.

Dr Reddys Laboratories's dividend payout ratio of 12.2% indicates that its dividend yield is sustainable for the long-term.

3. Select Medical Holdings (NYSE:SEM)

Select Medical Holdings (NYSE:SEM) has an annual dividend yield of 14.1%, which is 12 percentage points higher than the healthcare sector average of 2%. Select Medical Holdings's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Select Medical Holdings's dividend has not shown consistent growth over the last 10 years.

Select Medical Holdings's dividend payout ratio of 35.1% indicates that its high dividend yield is sustainable for the long-term.

Why are healthcare stocks down?

Healthcare stocks were down -0.19% in the last day, and up 4.59% over the last week. Leap Therapeutics was the among the top losers in the healthcare sector, dropping -28.02% yesterday.

Leap Therapeutics shares are trading lower after the company reported a Q2 EPS miss.

What are the most undervalued healthcare stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued healthcare stocks right now are:

1. Embecta (NASDAQ:EMBC)

Embecta (NASDAQ:EMBC) is the most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Embecta has a valuation score of 57, which is 41 points higher than the healthcare sector average of 16. It passed 4 out of 7 valuation due diligence checks.

Embecta's stock has dropped -5.97% in the past year. It has overperformed other stocks in the healthcare sector by 42 percentage points.

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the second most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 57, which is 41 points higher than the healthcare sector average of 16. It passed 4 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has gained 5.98% in the past year. It has overperformed other stocks in the healthcare sector by 54 percentage points.

3. Puma Biotechnology (NASDAQ:PBYI)

Puma Biotechnology (NASDAQ:PBYI) is the third most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Puma Biotechnology has a valuation score of 43, which is 27 points higher than the healthcare sector average of 16. It passed 3 out of 7 valuation due diligence checks.

Puma Biotechnology's stock has gained 95.95% in the past year. It has overperformed other stocks in the healthcare sector by 144 percentage points.

Are healthcare stocks a good buy now?

50.6% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 44.32% over the next year.

5.45% of healthcare stocks have a Zen Rating of A (Strong Buy), 12.32% of healthcare stocks are rated B (Buy), 42.3% are rated C (Hold), 26.54% are rated D (Sell), and 13.39% are rated F (Strong Sell).

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 7.22x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2025)
Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Phibro Animal Health (NASDAQ:PAHC)

2. Embecta (NASDAQ:EMBC)

3. Theravance Biopharma (NASDAQ:TBPH)

1. Simulations Plus (NASDAQ:SLP)

2. Dr Reddys Laboratories (NYSE:RDY)

3. Select Medical Holdings (NYSE:SEM)

1. Embecta (NASDAQ:EMBC)

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

3. Puma Biotechnology (NASDAQ:PBYI)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBest Healthcare Stocks to Buy Now (2025)Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Phibro Animal Health (NASDAQ:PAHC)

2. Embecta (NASDAQ:EMBC)

3. Theravance Biopharma (NASDAQ:TBPH)

1. Simulations Plus (NASDAQ:SLP)

2. Dr Reddys Laboratories (NYSE:RDY)

3. Select Medical Holdings (NYSE:SEM)

1. Embecta (NASDAQ:EMBC)

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

3. Puma Biotechnology (NASDAQ:PBYI)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2025)
Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.